» Articles » PMID: 19221491

Let-7 and MiR-200 MicroRNAs: Guardians Against Pluripotency and Cancer Progression

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2009 Feb 18
PMID 19221491
Citations 235
Authors
Affiliations
Soon will be listed here.
Abstract

Micro (mi)RNAs are emerging as important regulators of cellular differentiation, their importance underscored by the fact that they are often dysregulated during carcinogenesis. Two evolutionary conserved families, let-7 and miR-200, regulate key differentiation processes during development. Loss of let-7 in cancer results in reverse embryogenesis and dedifferentiation, and miR-200 has been identified as a powerful regulator of epithelial-to-mesenchymal transition (EMT). Recent findings have connected let-7 with stem cell maintenance and point at a connection between EMT and stem cell formation. A part of tumor progression can be viewed as a continuum of progressive dedifferentiation (EMT) with a cell at the endpoint that has stem cell-like properties. I propose that steps of this process are driven by specific changes in the expression of let-7 and miR-200 family members.

Citing Articles

Regulation of corneal epithelial differentiation: miR-141-3p promotes the arrest of cell proliferation and enhances the expression of terminal phenotype.

Ortiz-Melo M, Campos J, Sanchez-Guzman E, Herrera-Aguirre M, Castro-Munozledo F PLoS One. 2024; 19(12):e0315296.

PMID: 39642122 PMC: 11623785. DOI: 10.1371/journal.pone.0315296.


Stem Cell-Derived Exosomal MicroRNAs as Novel Potential Approach for Multiple Sclerosis Treatment.

Tahmasebi F, Asl E, Vahidinia Z, Barati S Cell Mol Neurobiol. 2024; 44(1):44.

PMID: 38713302 PMC: 11076329. DOI: 10.1007/s10571-024-01478-1.


Epithelial-mesenchymal transition in tissue repair and degeneration.

Youssef K, Nieto M Nat Rev Mol Cell Biol. 2024; 25(9):720-739.

PMID: 38684869 DOI: 10.1038/s41580-024-00733-z.


Role of STAT3 in cancer cell epithelial‑mesenchymal transition (Review).

Zhang G, Hou S, Li S, Wang Y, Cui W Int J Oncol. 2024; 64(5).

PMID: 38488027 PMC: 11000535. DOI: 10.3892/ijo.2024.5636.


Near-Infrared Induced miR-34a Delivery from Nanoparticles in Esophageal Cancer Treatment.

Alden N, Yeingst T, Pfeiffer H, Celik N, Arrizabalaga J, Helton A Adv Healthc Mater. 2024; 13(10):e2303593.

PMID: 38215360 PMC: 11032112. DOI: 10.1002/adhm.202303593.


References
1.
Wong S, Witte O . The BCR-ABL story: bench to bedside and back. Annu Rev Immunol. 2004; 22:247-306. DOI: 10.1146/annurev.immunol.22.012703.104753. View

2.
Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

3.
Peng Y, Laser J, Shi G, Mittal K, Melamed J, Lee P . Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res. 2008; 6(4):663-73. DOI: 10.1158/1541-7786.MCR-07-0370. View

4.
Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brannstrom M . E-cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer. 1997; 74(3):275-80. DOI: 10.1002/(sici)1097-0215(19970620)74:3<275::aid-ijc7>3.0.co;2-w. View

5.
Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View